Safety and effectiveness of intra-articular injection of a highly cross-linked hyaluronic acid, LBSA0103 (Synovian): Results from a post-marketing surveillance study in South Korea
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0287222 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Jae Gyoon Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Korea University College of Medicine Ansan Hospital, Gyeongki-do, Republic of Korea. Hauptthemen laut MEDLINE: Hyaluronic Acid, Osteoarthritis, Knee. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LG Chem.
Abstract (Originalsprache)
This study aimed to assess the safety and effectiveness of the highly cross-linked hyaluronic acid—LBSA0103—in patients with knee osteoarthritis (OA) as per the prescribing information (PI) in South Korea. A total of 3,140 subjects aged ≥19 years were enrolled in this post-marketing surveillance (PMS) study from 2013 to 2019. The subjects received one or two injections of LBSA0103. The median duration of follow-up was 308 days. Adverse events (AEs), adverse drug reactions (ADRs), and serious AEs (SAEs) were monitored. Effectiveness was evaluated based on an index of effectiveness in accordance with the guidelines established by the Ministry of Food and Drug Safety and using a 100-mm visual analog scale (VAS) for weight-bearing pain. Overall, 250 subjects (7.96%) experienced 292 AEs and of these, unexpected AEs occurred in 114 subjects (3.63% [95% CI: 3.00–4.35]). Injection site pain was the most frequent AE reported by 81 subjects (2.58% [95% confidence intervals (CI): 2.05–3.20]). One hundred subjects experienced 108 ADRs (3.18% [95% CI: 2.60, 3.86]) and 15 unexpected ADRs were experienced by 13 subjects (0.41% [95% CI: 0.22–0.71]). Seventeen subjects experienced 22 SAEs (0.54% [95% CI: 0.32–0.87]) during the entire PMS period, and all were considered “unlikely” related to the study drug. Most AEs were mild in terms of severity and resolved during the study period. LBSA0103 was also effective in relieving symptomatic pain in knee OA patients. The condition in more than 80% of the subjects was considered to be improved when assessed by the investigators. LBSA0103 resulted in a significant reduction in the mean VAS score at 12 weeks after the first and second injections (24.79 (± 20.55) mm and 17.63 (±12.31) mm, respectively; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Korea University College of Medicine Ansan Hospital, Gyeongki-do, Republic of Korea.
- Department of Orthopedic Surgery, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
- Department of Orthopedic Surgery, Good Samsun Hospital, Busan, Republic of Korea.
- Department of Orthopedic Surgery, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Republic of Korea.
- Department of Orthopedic Surgery, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
- Department of Orthopedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Republic of Korea.
ORCID-Profile: Kang-Il Kim
Förderung
- LG Chem
Zitieren
APA
Kim, J. G., Kim, K. I., Park, K. B., Park, Y. G., Bae, J. H., Seo, Y. J., Seon, J. K., Shon, O. J., Ahn, J. H., Wang, L., Wang, J. H., Choi, E. S., Ha, J. K., Han, H. S., & Moon, S. W. (2023). Safety and effectiveness of intra-articular injection of a highly cross-linked hyaluronic acid, LBSA0103 (Synovian): Results from a post-marketing surveillance study in South Korea. PLOS ONE. https://doi.org/10.1371/journal.pone.0287222
Vancouver
Kim JG, Kim KI, Park KB, Park YG, Bae JH, Seo YJ, et al. Safety and effectiveness of intra-articular injection of a highly cross-linked hyaluronic acid, LBSA0103 (Synovian): Results from a post-marketing surveillance study in South Korea. PLOS ONE. 2023. doi:10.1371/journal.pone.0287222
BibTeX
@article{Kim2023,
author = {Kim, Jae Gyoon and Kim, Kang-Il and Park, Ki-Bong and Park, Yong-Geun and Bae, Ji Hoon and Seo, Young-Jin and Seon, Jong-Keun and Shon, Oog Jin and Ahn, Ji Hyun and Wang, Lih and Wang, Joon-Ho and Choi, Eui Sung and Ha, Jeong-Ku and Han, Hyuk-Soo and Moon, Sang Won},
title = {Safety and effectiveness of intra-articular injection of a highly cross-linked hyaluronic acid, LBSA0103 (Synovian): Results from a post-marketing surveillance study in South Korea},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0287222}
}
EUVIMED